Insider trades
OrbiMed Capital GP VI, Director of Prelude Therapeutics PRLD, has filed 25 purchases and 75 sales on the open market. Over the past 12 months that comes to a net purchase of $16.8M. The latest trade was on 04/21.
OrbiMed Capital GP VI
Director
- Company
- Prelude Therapeutics PRLD
- First filing
- 23/01/03
- Trades
- 123 trades
- Buys / sales
- 25 / 75
- 12-month net buying
- $16.8M
- Last trade
- 04/21
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
PRLD | Open-market buy | 04/21 | 04/23 | 2,815,315 sh2 trades | $4.44avg. | $12,499,998.6 | No record |
ACET | Open-market sale | 04/07–04/08 | 04/09 | 104,658 sh4 trades | $6.45avg. | $674,847.06 | −100.0% |
ACET | Open-market buy | 25/10/08 | 25/10/10 | 5,000,000 sh2 trades | $1.00avg. | $5,000,000 | No record |
NPCE | Open-market sale | 25/05/14 | 25/05/16 | 168,136 sh2 trades | $15.85avg. | $2,665,332.88 | −4.9% |
| Open-market sale | 25/04/09 | 25/04/11 | 3,571,428 sh | $1.59 | $5,678,570.52 | −100.0% | |
EWTX | Open-market buy | 25/04/03 | 25/04/04 | 496,771 sh2 trades | $20.13avg. | $10,000,000.23 | No record |
IRON | Open-market sale | 25/03/24 | 25/03/26 | 5,738 sh3 trades | $54.11avg. | $310,483.18 | −3.0% |
IRON | Open-market sale | 25/03/19–25/03/21 | 25/03/21 | 52,429 sh9 trades | $54.02avg. | $2,831,986.74 | −21.9% |
IRON | Open-market sale | 25/03/10–25/03/12 | 25/03/12 | 312,384 sh15 trades | $54.31avg. | $16,965,596.07 | −61.7% |
| Open-market sale | 24/08/26 | 24/08/28 | 83,695 sh | $13.00 | $1,088,035 | −100.0% | |
SPRY | Open-market sale | 24/08/21–24/08/23 | 24/08/23 | 868,682 sh4 trades | $13.24avg. | $11,497,963.08 | −91.2% |
| Open-market buy | 24/08/13 | 24/08/15 | 500,000 sh2 trades | $4.00avg. | $2,000,000 | No record | |
IRON | Open-market buy | 24/06/17 | 24/06/20 | 83,334 sh3 trades | $36.00avg. | $3,000,024 | +54.8% |
NPCE | Open-market sale | 24/05/01–24/05/03 | 24/05/03 | 29,206 sh3 trades | $14.02avg. | $409,426.44 | −0.9% |
NeuroPaceNPCE | Open-market sale | 24/04/24 | 24/04/26 | 1,781 sh | $14.06 | $25,040.86 | −0.1% |
NPCE | Open-market sale | 24/04/19–24/04/23 | 24/04/23 | 64,653 sh3 trades | $14.12avg. | $913,056.9 | −1.8% |
NPCE | Open-market sale | 24/04/16–24/04/18 | 24/04/18 | 16,992 sh3 trades | $14.02avg. | $238,231.07 | −0.5% |
NPCE | Open-market sale | 24/04/11–24/04/12 | 24/04/15 | 485,000 sh2 trades | $14.49avg. | $7,026,032.93 | −12.1% |
ACET | Open-market buy | 24/01/25 | 24/01/26 | 3,125,000 sh3 trades | $2.40avg. | $7,500,000 | No record |
| Open-market buy | 24/01/23 | 24/01/25 | 454,545 sh | $11.00 | $4,999,995 | +3.3% |
